The Pediatric Endocrinologist’s Role in the Diagnosis of Hypertension in Girls with Turner Syndrome

Abstract

Cardiovascular disease is the major morbidity reducing lifespan in Turner Syndrome (TS) and systemic hypertension is the most readily treatable risk factor for preventing ischemic heart disease, stroke, aortic dissection and rupture [1]. Yet hypertension has few overt symptoms and can go unrecognized and untreated unless providers are attuned to the importance of appropriate screening, diagnosis and treatment in this population.